Annual report pursuant to Section 13 and 15(d)

PARENT COMPANY FINANCIALS. (Details 2)

v3.8.0.1
PARENT COMPANY FINANCIALS. (Details 2) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Operating Activities:                      
Net income (loss) $ (13,285) $ (202) $ (8,841) $ (12,636) $ 13,077 $ (3,518) $ 5,086 $ (13,226) $ (34,964) $ 1,419 $ (18,786)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:                      
Fair value adjustments                 (473) 557 (1,641)
Asset impairment                 1,970
Deferred income taxes                 169 (1,122) (2,023)
Amortization of debt discounts                 636 2,322 716
Changes in operating assets and liabilities:                      
Accounts receivables                 17,562 (25,235) (15,950)
Other assets                 6,738 (3,973) 5,622
Accounts payable and accrued expenses                 (5,538) 9,279 (10,045)
Net cash provided by (used in) operating activities                 36,509 37,228 (27,993)
Investing Activities:                      
Additions to property and equipment                 (20,866) (19,171) (20,507)
Net cash used in investing activities                 (50,440) (14,597) (6,325)
Financing Activities:                      
Proceeds from issuances of senior notes                 13,530 53,350
Proceeds from warrant stock option exercises                 1,202 1,164 368
Net cash provided by (used in) financing activities                 (839) (9,922) 23,795
Net decrease in cash and cash equivalents                 (14,770) 12,709 (10,523)
Cash and cash equivalents at beginning of period       64,259       51,550 64,259 51,550 62,073
Cash and cash equivalents at end of period 49,489       64,259       49,489 64,259 51,550
Parent Company [Member]                      
Operating Activities:                      
Net income (loss)                 (34,964) 1,419 (18,786)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:                      
Equity in losses of subsidiaries                 28,346 5,137 29,724
Dividends from subsidiaries                 3,500
Depreciation and amortization                 830 727 390
Fair value adjustments                 (473) 557 (1,641)
Asset impairment                 1,970
Deferred income taxes                 169 (1,122) (14,260)
Amortization of debt discounts                 636 10
Changes in operating assets and liabilities:                      
Accounts receivables                 4,065 7,302 (5,958)
Other assets                 4,356 4,647 (4,139)
Accounts payable and accrued expenses                 3,859 (3,741) 604
Accounts payable with subsidiaries                 (943) (9,385) 11,179
Net cash provided by (used in) operating activities                 9,381 5,551 (917)
Investing Activities:                      
Additions to property and equipment                 (468) (465) (1,483)
Investments in subsidiaries                 (28,126) (50,886)
Purchase of PE OP Co. debt                 (17,003)
Net cash used in investing activities                 (28,594) (68,354) (1,483)
Financing Activities:                      
Proceeds from issuances of senior notes                 13,530 53,350
Proceeds from warrant stock option exercises                 1,202 1,164 368
Preferred stock dividend payments                 (1,265) (1,269) (1,265)
Net cash provided by (used in) financing activities                 13,467 53,245 (897)
Net decrease in cash and cash equivalents                 (5,746) (9,558) (3,297)
Cash and cash equivalents at beginning of period       $ 11,060       $ 20,618 11,060 20,618 23,915
Cash and cash equivalents at end of period $ 5,314       $ 11,060       $ 5,314 $ 11,060 $ 20,618